Alvaro
Lassaletta Atienza
Consultor Médico
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicacions en col·laboració amb investigadors/es de Dana–Farber Cancer Institute (3)
2023
-
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation Sparing Approaches: An International Cohort Study
Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1921-1932
-
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695
2021
-
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance
Journal of Clinical Oncology, Vol. 39, Núm. 25, pp. 2779-2790